- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
46 Cards in this Set
- Front
- Back
|
Aspart and Lispro are ____ acting insulins
|
Rapid
|
|
Gargine is a ____ acting insulin
|
Long
|
|
May produce Disulfiram like rxn and may also potentiate the effects of ADH --> hypOnatremia
|
Sulfonylureas (Tolbutamide, Chlopropamide - both 1st generations with the most SE, Glycuride, Glipizide, Glimepiride- 2nd generations with < SE)
|
|
What class of drugs is Tolbutamide in?
|
1st gen Sulfonylurea
|
|
What class of drugs is Chlorpropamide in?
|
1st gen Sulfonylurea
|
|
What class of drugs is Glyburide in?
|
2nd gen sulfonylurea
|
|
What class of drugs is Glipizide in?
|
2nd gen sulfonylurea
|
|
What class of drugs is Glimepiride in?
|
2nd gen sulfonylurea
|
|
Name 2 groups of drugs that bind to a distinct site on the SUR receptor of ATP-sensitive K+ channels resulting in depolarization and Ca++ influx (causing > secretion of pro-insulin)
|
Sulfonylureas and Meglitinides/Glinides
|
|
How are Repaglinidie and Nateglinide different from Sulfonylureas?
|
Rapid onset and short DOA
|
|
Contraindications for using sulfonylureas?
|
Pts with liver or kidney failure
|
|
Name the two long acting sulfonylureas
|
Chlorpropamide and Glimepiride
|
|
What type of diabetes do you use sulfonylureas in?
|
Type II
|
|
Do not use Meglitinides/Glinides in pts with what?
|
hepatic impairment
|
|
What drugs should you NOT use with Meglitinides/Glinides?
|
Gemfibrozil (hypoglycemia) and sulfonylureas
|
|
Azoles, erythromycin/Clarithromycin may do what to do what to the concentration of Meglitinides/Glinides?
|
> the effects by > the concentration (these drugs inhibit CYP34A that normally metabolizes Repaglinide and Nateglinide)
|
|
Barbs, Carbamazepine and Rifampin may do what to do what to the concentration of Meglitinides/Glinides?
|
May < the effects due to < concentration (these drugs > CYP34A actions)
|
|
What is the Biguanide drug?
|
Metformin
|
|
MOA of Metformin
|
> glucose uptake and use by target tissues; increases peripheral insulin sensitivity; inhibits hepatic gluconeogensis
|
|
Drug of choice for newly Dx T2D
|
Metformin
|
|
Name 2 SE of Metformin
|
Metallic taste and Lactic acidosis, also < weight, GI
|
|
Metformin is CONTRA in which pts?
|
Renal/Hepatic disease, ETOH use, elderly and in pts with DKA
|
|
When should you D/C Metformin?
|
In cases of MI, CHG, infection, contrast dyes
|
|
MOA of Thiazolidinediones "Glitazones"
|
Bind to PPAR-y, a nuclear hormone receptor and regulates adipocyte production and secretion of FA and glucose metabolism--> > insulin sensitivity in adipose tisse, liver and skeletal muscle
|
|
What drug class are Rosiglitazone and Pioglitazone in?
|
Thiazolidinediones
|
|
How do the Thiazolidinediones increase glucose uptake and utilization?
|
> synthesis and transport of GLUT4 and GLUT2 transporters in muscle, adipose and liver
|
|
Thiazolidinediones require what for action?
|
Insulin
|
|
PPARy receptor agonists
|
Rosiglitazone and Pioglitazone
|
|
Thiazolidinediones are CONTRA in who?
|
nursing mammas
|
|
SE of Thiazolidinediones?
|
Edema, URI, headache, Hepatotoxic?
Rosiglitazone has an MI risk |
|
Synthetic amylin Analog
|
Pramlintide
|
|
MOA of Pramlintide
|
< carb absorption, < glucose production by th eliver; inhibits glucose sythesis in the liver
|
|
When may Pramlintide induce severe hypOglycemia?
|
When used with insulin and not adjusting the does of insulin (Thus, reduce the dose of SAI by 50% prior to meals!)
|
|
Name the 2 alpha-glucosidase inhibitors
|
Acarbose and Miglitol
|
|
MOA of Acarbose and Miglitol?
|
Reversibly inhibit membrane bound alpha-glucosdiase in the intestinal BB which is responsible for the hydrolyisis of oligosaccharids to tglucose and other monosaccharides; delay digestion of carbs
|
|
In what way are Acarbose and Miglitol unlike any of the other Diabetes drugs?
|
they neither stimulate insulin relase nore increase insulin action in target tissues; just delay the digestion of carbs
|
|
Of the two alpha glucosidase inhibitors, which is metabolized by intestinal bacteria?
|
Acarbose (not absorbed); Miglitol is very well absorbed but has no systemic effects
|
|
Alpha glucosidase inhibitors (Acarbose and Miglitol) are CONTRA in which pts?
|
IBD, colonic ulceration or intestinal obstruction
|
|
What drug group is Exenatide in?
|
Incretin Analog (GLP-1 analog)
|
|
MOA of Exenatide
|
Incretin analog; > insulin and < glucagon secretion
|
|
What group of drugs are Sitagliptin and Saxagliptin in?
|
DDP-IV Inhibitors
|
|
What enzyme degrades GLP-1?
|
Dipeptidyl peptidase-4
|
|
MOA of Sitagliptin and Saxagliptin?
|
DDP-IV Inhibitors
|
|
Inhibits Dipeptidyl Peptidase 4
|
Sitagliptin and Saxagliptin, thus < glucagon and glucose
|
|
SE of Sitagliptin and Saxagliptin
|
usually well tolerated, but nasopharyngitis, headache and pancreatitis
|
|
Target Blood Glucose and A1C
|
115 mg/Dl or less and 7% or less
|